Seaford mum's second Poland trip for op

A MOTHER from Seaford has travelled to Poland with her MS sufferer daughter for a second time for an operation.

Michele Findlay told the Gazette in February how she and her daughter Ella would be travelling to the country later that month to undergo tests in a bid to improve the 31-year-old's condition.

During the first visit Ella, who was diagnosed with multiple sclerosis 10 years ago, found she had Chronic Cerebro-Spinal Venous Insufficiency (CCSVI).

This follows a preliminary study by a leading surgeon called Dr Paolo Zamboni who used ultrasound and magnetic resonance venography to examine the blood vessels leading in and out of the brain of hundreds of patients.

He found the majority of all his patients with multiple sclerosis he treated had defective circulation in their neck – a defect he has called CCSVI.

After finding that Ella had CCSVI she had a liberation treatment which in her case involved being injected with an opaque dye and then a deflated balloon is guided up to the point of constriction and once there is inflated to widen the vein.

After returning from Poland Mrs Findlay said her daughter had shown some signs of improvement including being able to walk longer distances and her feet being warmer but weeks later she lost these benefits.

So the pair flew abroad again and Ella underwent a second liberation procedure and a stent was placed in her right jugular which had re-stenosed.

Michele, who earlier this year joined other MS-CCSVI-UK members to present a petition calling for clinical research into CCSVI procedures to take place in the UK at 10 Downing Street, said, "You don't think about having an operation as a pleasure but it was nice to see them again and our second impression was as good as the first time and the procedure went quite well.

"She has had timed tests which involve things such as walking for 10 metres and standing up from a sitting position walking five metres, turning around and going back and sitting down – in both cases her times have improved by a second which is around 10 per cent improvement.

"It's early days and there's still time for improvement."

Michele will be joining around 20 members of MS-CCSVI-UK today (Wednesday) for a meeting with the chief executive of the Multiple Sclerosis Society. They will be talking about various issues including their campaigning for clinical research into the CCSVI procedure to start taking place in the UK.